Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Busse

Showing results (551-560 of 1,163) with videos related to

Pageof 117
Sort By:
The Journal of Allergy and Clinical Immunology|September 10, 2004
Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxinJulie B Sedgwick, Rose F Vrtis, Kristyn J Jansen, et al.
BMC Pulmonary Medicine|July 11, 2014
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised studyAshley Woodcock, Jan Lötvall, William W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2013
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthmaWilliam W Busse, Stephen Holgate, Edward Kerwin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2026
Mepolizumab Demonstrates Quantifiable Reduction in Corticosteroid-Related Adverse Effects in Severe AsthmaNjira L Lugogo, Jared Silver, William W Busse, et al.
The American Review of Respiratory Disease|April 1, 1979
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccinesW W Busse, W Cooper, D M Warshauer, et al.
Pulmonary Pharmacology & Therapeutics|November 28, 2015
Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studiesP Chervinsky, E O Meltzer, W Busse, et al.
Epidemiology (Cambridge, Mass.)|January 9, 2004
Interpreting authorship order and corresponding authorshipMohit Bhandari, Jason W Busse, Abhaya V Kulkarni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challengeMats W Johansson, Elizabeth A B Kelly, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2000
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukastH S Nelson, W W Busse, E Kerwin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 6, 2019
Interventional pain management for chronic pain: a survey of physicians in CanadaHarsha Shanthanna, Anuj Bhatia, Mohan Radhakrishna, et al.
Pageof 117

Showing results (551-560 of 1,163) with videos related to

Sort By:
Pageof 117
The Journal of Allergy and Clinical Immunology|September 10, 2004
Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxinJulie B Sedgwick, Rose F Vrtis, Kristyn J Jansen, et al.
BMC Pulmonary Medicine|July 11, 2014
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised studyAshley Woodcock, Jan Lötvall, William W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2013
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthmaWilliam W Busse, Stephen Holgate, Edward Kerwin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2026
Mepolizumab Demonstrates Quantifiable Reduction in Corticosteroid-Related Adverse Effects in Severe AsthmaNjira L Lugogo, Jared Silver, William W Busse, et al.
The American Review of Respiratory Disease|April 1, 1979
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccinesW W Busse, W Cooper, D M Warshauer, et al.
Pulmonary Pharmacology & Therapeutics|November 28, 2015
Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studiesP Chervinsky, E O Meltzer, W Busse, et al.
Epidemiology (Cambridge, Mass.)|January 9, 2004
Interpreting authorship order and corresponding authorshipMohit Bhandari, Jason W Busse, Abhaya V Kulkarni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challengeMats W Johansson, Elizabeth A B Kelly, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2000
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukastH S Nelson, W W Busse, E Kerwin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 6, 2019
Interventional pain management for chronic pain: a survey of physicians in CanadaHarsha Shanthanna, Anuj Bhatia, Mohan Radhakrishna, et al.
Pageof 117